Parvizi Surgical Innovation
Overview
Parvizi Surgical Innovation is a healthcare-focused accelerator and incubator that fosters the growth of new technologies through funding, partnership, research, and innovative development.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| PrecisionOS | Jan 2021 | Strategic | Lead |
| GeneSpark Diagnostics | Aug 2020 | Series B | Co-investor |
| Aravis BioTech | Oct 2023 | Seed | Lead |
Key People
Michael M. Kheir
Vice President Of Medical Affairs
Tiffany Morrison
Vice President Research And Development
Timothy Ladin
Board Member and Chief Legal Officer
David Kirschman
Board Director
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Parvizi Surgical Innovation based?
Parvizi Surgical Innovation is headquartered in Philadelphia, Pennsylvania, United States.
When was Parvizi Surgical Innovation founded?
Parvizi Surgical Innovation was founded in 2016.
How many portfolio companies does Parvizi Surgical Innovation have?
Parvizi Surgical Innovation has 3 portfolio companies in Caplight's dataset.
What are some companies in Parvizi Surgical Innovation's portfolio?
Portfolio companies visible on Caplight include PrecisionOS, GeneSpark Diagnostics, Aravis BioTech.
What was Parvizi Surgical Innovation's most recent investment shown here?
Parvizi Surgical Innovation's most recent investment in this portfolio sample was in Aravis BioTech in 2023.
What sectors does Parvizi Surgical Innovation focus on?
Parvizi Surgical Innovation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software.
What company stages does Parvizi Surgical Innovation focus on?
Parvizi Surgical Innovation typically invests at the Early stage.